bumetrizole은 임신 중 안전한가요?
No harmonised CLP reproductive classification (no H360/H361) or SCCS/CIR safety opinion was identified for bumetrizole (UV‑326); guideline reproductive/developmental studies in rodents reported no reproductive/developmental effects up to high oral doses, supporting no evidence of a reproductive hazard. However, environmental/biomonitoring data show the compound is bioaccumulative and has been detected in human matrices, so dermal exposure from cosmetics is plausibly low but measurable. (Sources: ECHA registration/MSC materials; Canada/OECD summary; biomonitoring literature).
Related ingredients
Frequently asked questions
- bumetrizole은 임신 중 안전한가요?
- No harmonised CLP reproductive classification (no H360/H361) or SCCS/CIR safety opinion was identified for bumetrizole (UV‑326); guideline reproductive/developmental studies in rodents reported no reproductive/developmental effects up to high oral doses, supporting no evidence of a reproductive hazard. However, environmental/biomonitoring data show the compound is bioaccumulative and has been detected in human matrices, so dermal exposure from cosmetics is plausibly low but measurable. (Sources: ECHA registration/MSC materials; Canada/OECD summary; biomonitoring literature).
- bumetrizole은 모유 수유 중 안전한가요?
- No reproductive or lactation-specific hazard classification was found. Bumetrizole has been detected in human matrices including reports of detection in breast milk/biomonitoring programs, indicating low but measurable potential for transfer to breastfed infants rather than a demonstrated toxic effect. (Sources: biomonitoring and regulatory assessments).
- bumetrizole은 아기 피부에 안전한가요?
- No infant-specific toxicology indicating increased hazard was identified. Because bumetrizole shows potential for systemic uptake and bioaccumulation (high log Kow, biomonitoring detections), and immature infant skin has higher absorption per weight, exposure scoring is increased by +1 above adult exposure (adult e=1 → infant e=2) though no infant hazard data were found. (Sources: toxicokinetic/biomonitoring and regulatory summaries).
- VeriMom은 bumetrizole을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 bumetrizole을 93/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 bumetrizole 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.